Endogenous glucocorticoids may serve as biomarkers for migraine chronification.
Yohannes W WoldeamanuelBharati M SanjanwalaRobert P CowanPublished in: Therapeutic advances in chronic disease (2020)
Endogenous glucocorticoids may be biomarkers for migraine progression and for monitoring treatment response. Improving pain self-efficacy skills may help optimize endogenous glucocorticoid levels, which in turn may prevent migraine attacks.